Literature DB >> 32730645

Site-specific contribution of Toll-like receptor 4 to intestinal homeostasis and inflammatory disease.

Elise E Bruning1, Janet K Coller2, Hannah R Wardill1,3, Joanne M Bowen1.   

Abstract

Toll-like receptor 4 (TLR4) is a highly conserved protein of innate immunity, responsible for the regulation and maintenance of homeostasis, as well as immune recognition of external and internal ligands. TLR4 is expressed on a variety of cell types throughout the gastrointestinal tract, including on epithelial and immune cell populations. In a healthy state, epithelial cell expression of TLR4 greatly assists in homeostasis by shaping the host microbiome, promoting immunoglobulin A production, and regulating follicle-associated epithelium permeability. In contrast, immune cell expression of TLR4 in healthy states is primarily centred on the maturation of dendritic cells in response to stimuli, as well as adequately priming the adaptive immune system to fight infection and promote immune memory. Hence, in a healthy state, there is a clear distinction in the site-specific roles of TLR4 expression. Similarly, recent research has indicated the importance of site-specific TLR4 expression in inflammation and disease, particularly the impact of epithelial-specific TLR4 on disease progression. However, the majority of evidence still remains ambiguous for cell-specific observations, with many studies failing to provide the distinction of epithelial versus immune cell expression of TLR4, preventing specific mechanistic insight and greatly impacting the translation of results. The following review provides a critical overview of the current understanding of site-specific TLR4 activity and its contribution to intestinal/immune homeostasis and inflammatory diseases.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  Toll-like receptor 4; immunity; inflammation; intestines; mucous membrane

Year:  2020        PMID: 32730645     DOI: 10.1002/jcp.29976

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  5 in total

Review 1.  Exosomes Derived From Mesenchymal Stem Cells: Novel Effects in the Treatment of Ischemic Stroke.

Authors:  Yu Xiong; Jianping Song; Xinyue Huang; Zhigang Pan; Roland Goldbrunner; Lampis Stavrinou; Shu Lin; Weipeng Hu; Feng Zheng; Pantelis Stavrinou
Journal:  Front Neurosci       Date:  2022-05-02       Impact factor: 5.152

2.  Mesenchymal stem cell-derived exosome miR-542-3p suppresses inflammation and prevents cerebral infarction.

Authors:  Guofeng Cai; Guoliang Cai; Haichun Zhou; Zhe Zhuang; Kai Liu; Siying Pei; Yanan Wang; Hong Wang; Xin Wang; Shengnan Xu; Cheng Cui; Manchao Sun; Sihui Guo; Kunping Jia; Xiuzhen Wang; Dianquan Zhang
Journal:  Stem Cell Res Ther       Date:  2021-01-06       Impact factor: 6.832

3.  Development of a self-limiting model of methotrexate-induced mucositis reinforces butyrate as a potential therapy.

Authors:  A R da Silva Ferreira; S A J van der Aa; T Wehkamp; H R Wardill; J P Ten Klooster; J Garssen; L F Harthoorn; A Hartog; H J M Harmsen; W J E Tissing; J van Bergenhenegouwen
Journal:  Sci Rep       Date:  2021-11-25       Impact factor: 4.379

4.  Intestinal TLR4 deletion exacerbates acute pancreatitis through gut microbiota dysbiosis and Paneth cells deficiency.

Authors:  Mei Qi-Xiang; Fu Yang; Huang Ze-Hua; Yin Nuo-Ming; Wang Rui-Long; Xu Bin-Qiang; Fan Jun-Jie; Huang Chun-Lan; Zeng Yue
Journal:  Gut Microbes       Date:  2022 Jan-Dec

5.  Impairment in the Intestinal Morphology and in the Immunopositivity of Toll-like Receptor-4 and Other Proteins in an Autistic Mouse Model.

Authors:  Caterina Franco; Marzia Gianò; Gaia Favero; Rita Rezzani
Journal:  Int J Mol Sci       Date:  2022-08-05       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.